Category Archives: TRIPS flexibilities

Compulsory licensing required for essential drugs: Y K Hamied

Pragmatic compulsory licensing policy is needed to enable India to look after health of its people as it cannot afford monopoly in healthcare with the challenges it faces, Cipla’s Y K Hamied said.

Posted in Compulsory Licensing, Uncategorized | Leave a comment

European Commission publishes negotiating proposals for EU-Indonesia trade deal

It is important to note that the EU proposals on IP are TRIPS-plus in multiple regards and would surely reduce policy space in Indonesia and negatively impact access to affordable medicines.  Even a preliminary review of the proposal reveals: A … Continue reading

Posted in IPR Enforcement, Patent Term Extension, TRIPS, TRIPS flexibilities, TRIPS plus, Uncategorized | Leave a comment

How charity is fuelling a superbug in India?

By Ruhi Khandar, The Ken The evil superbug is on the lookout for new hosts. The hero has the weapon, he can conquer it, but only if he is willing. The superbug is antibiotic-resistant bacteria, which causes multi-drug-resistant tuberculosis (MDR-TB), the … Continue reading

Posted in Compulsory Licensing, Drugs, Tuberculosis (TB), Uncategorized | Tagged , , | Leave a comment

It’s Official: TRIPS Health Amendment In Effect, First Ever To A WTO Agreement

Source: http://www.ip-watch.org More than a decade after World Trade Organization member states approved the first-ever legal amendment to a WTO agreement, the change to the international intellectual property agreement has entered into effect. Five more members ratified the amendment in … Continue reading

Posted in Compulsory Licensing, Doha Declaration, TRIPS, TRIPS flexibilities, Uncategorized, WTO | Leave a comment

New Book Highlights IP Trade Law Flexibilities For Public Health

Source: http://www.ip-watch.org A recently published book by a high-impact public health advocate provides new analysis on the use of flexibilities in international trade law relating to intellectual property rights aimed at advancing discussions on solutions to high drug prices worldwide. … Continue reading

Posted in IPR, TRIPS, TRIPS flexibilities, Uncategorized, WTO | Leave a comment

India at WTO: Takes strong stand to save generic drugs industry, calls for transparent health assessment

By Shreerupa Mitra-Jha, FirstPost | November 13, 2016 Governments engaged in bilateral and regional trade investments should ensure that these agreements do not include provisions that impinge on the right to health, and as a first step should undertake public health … Continue reading

Posted in TRIPS, TRIPS flexibilities, TRIPS plus, Uncategorized, UNHLP report, WHO | Leave a comment

India to US: Will not tighten IPR rules beyond TRIPS mandate

Commerce Minister Nirmala Sitharaman demands food safety clearance mechanism during talks with US Trade Representative Source: The Hindu BusinessLine | October 20, 2016 India and the US continued to differ on the issue of intellectual property rights (IPR) norms at … Continue reading

Posted in Compulsory Licensing, Data Exclusivity, Evergreening, IPR, Patent linkage, Sec 3 (d), TRIPS, TRIPS plus, Uncategorized, UNHLP report, USTR 301 report | Leave a comment